Search results
Pfizer to test third dose of COVID-19 vaccine in children
AOL· 10 hours agoThe decision was made after an analysis showed the two-dose vaccine generated an immune response in...
Pfizer pauses phase 3 dosing in gene therapy trial after young boy's death
FierceBiotech· 20 hours agoA young boy with Duchenne muscular dystrophy (DMD) participating in Pfizer’s phase 2 gene therapy...
Pfizer reports patient death in Duchenne gene therapy study
Reuters via AOL· 19 hours ago(Reuters) -A young patient died due to cardiac arrest after receiving Pfizer's experimental gene...
Will withdrawal of AstraZeneca vaccine affect your next COVID booster jab?
Yahoo News UK· 2 hours agoAgency advice on bookings set out the vaccines that would be used. The guidance said that only mRNA ...
AstraZeneca: What are the rare side effects of the Covid jab?
The Independent via Yahoo News· 6 hours agoHowever, the government largely stopped using the jab and it was replaced in the UK with Pfizer and...
AstraZeneca withdraws Covid-19 jab from the market
PA Media: Science via Yahoo News· 3 hours ago“There would have been far more deaths, hospitalisations, illness and transmission, if we hadn’t had the AstraZeneca vaccine, alongside the other key...
AstraZeneca pulls Covid vaccine after admitting rare side effect
Daily Express· 17 hours agoThe Oxford-AstraZeneca Covid vaccine is set to be withdrawn after the pharmaceutical giant admitted...
Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 16 minutes agoAclaris Therapeutics, Inc. (NASDAQ:ACRS) Q1 2024 Earnings Call Transcript May 7, 2024 Aclaris...
AstraZeneca removes Covid vaccine after very rare side effect linked to deaths
The US Sun· 5 hours agoIt is another sign that the outbreak is consigned to history after the World Health Organisation...
Pfizer Inc. (NYSE:PFE) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 6 days agoPfizer Inc. (NYSE:PFE) Q1 2024 Earnings Call Transcript May 1, 2024 Pfizer Inc. beats earnings...
